Your browser doesn't support javascript.
loading
Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome.
Yoshihama, Tomoko; Hirasawa, Akira; Sugano, Kokichi; Yoshida, Teruhiko; Ushiama, Mineko; Ueki, Arisa; Akahane, Tomoko; Nanki, Yoshiko; Sakai, Kensuke; Makabe, Takeshi; Yamagami, Wataru; Susumu, Nobuyuki; Kameyama, Kaori; Kosaki, Kenjiro; Aoki, Daisuke.
Afiliación
  • Yoshihama T; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Hirasawa A; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Sugano K; Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558 Japan.
  • Yoshida T; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  • Ushiama M; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  • Ueki A; Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, Tochigi, Japan.
  • Akahane T; Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Nanki Y; Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Sakai K; Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Makabe T; Center for Medical Genetics, Keio University School of Medicine, Tokyo, Japan.
  • Yamagami W; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Susumu N; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Kameyama K; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Kosaki K; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • Aoki D; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Int Cancer Conf J ; 10(1): 6-10, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33489693

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Int Cancer Conf J Año: 2021 Tipo del documento: Article País de afiliación: Japón